Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Lowered to $220 00 at Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $18.15-$19.35 for the period, compared to the consensus estimate of $19.94. The company issued revenue guidance of $4.0-$4.2 billion, compared to the consensus revenue estimate of $4.08 billion. Jazz Pharmaceuticals also updated […]
Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Cut to $170 00 by Analysts at JPMorgan Chase & Co themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Qube Research & Technologies Ltd Reduces Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Aristotle Capital Management LLC purchased a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 175,757 shares of the specialty pharmaceutical company’s stock, valued at approximately $22,748,000. Aristotle Capital […]